{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:26:37Z","timestamp":1784661997424,"version":"3.55.0"},"reference-count":17,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,1,13]],"date-time":"2002-01-13T00:00:00Z","timestamp":1010880000000},"content-version":"vor","delay-in-days":165,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutic Apheresis"],"published-print":{"date-parts":[[2001,8]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> Immunoadsorption therapy has become popular for the treatment of various autoimmune diseases as the number of clinically available immunoadsorption columns increases. Immunoadsorption columns for plasma perfusion or direct hemoperfusion available for clinical use such as the Immusorba TR and PH, Selesorb, Prosorba, Immunosorba, Ig\u2010Therasorb, and Medisorba MG are reviewed in the first part of this article. The peptide columns which immobilize peptides as the ligands are described in the second half. The peptide column has the potential to deliver specific adsorbents if a peptide is appropriately designed to remove the pathogenic substances specifically responsible for the given disease.<\/jats:p>","DOI":"10.1046\/j.1526-0968.2001.00360.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T21:00:37Z","timestamp":1047502837000},"page":"301-305","source":"Crossref","is-referenced-by-count":18,"title":["Current Topics on Immunoadsorption Therapy"],"prefix":"10.1111","volume":"5","author":[{"given":"Shuhei","family":"Nakaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,13]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.1997.tb00150.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.1998.tb00102.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.5.578"},{"key":"e_1_2_5_5_2","first-page":"545","article-title":"Selective removal of anti\u2010DNA and anticardiolipin antibodies by adsorbent plasmapheresis using dextran sulfate columns in patients with systemic lupus erythematosus.","volume":"18","author":"Hashimoto H","year":"1991","journal-title":"J Rheumatology"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.1998.tb00068.x"},{"key":"e_1_2_5_7_2","first-page":"804","article-title":"Treatment of patients with refractory rheumatoid arthritis with extracorporeal protein\u2010A immunoadsorption column: A pilot trial.","volume":"21","author":"Wiesenhuter C","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199910)42:10<2153::AID-ANR16>3.0.CO;2-W"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.1999.00155.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.1998.tb00093.x"},{"key":"e_1_2_5_11_2","unstructured":"Oka K Nakaji S Tanihara M Takakura K Takamori M. Development of specific immunoadsorbent containing immobilized synthetic peptide of acetylcholine receptor for treatment of myasthenia gravis.Jpn J Artif Organs1993;22:194\u20137."},{"key":"e_1_2_5_12_2","first-page":"573","article-title":"Development of a specific immunoadsorbent containing immobilized synthetic peptide of acetylcholine receptor for treatment of myasthenia gravis.","volume":"12","author":"Nakaji S","year":"1993","journal-title":"Ther Plasmapheresis"},{"key":"e_1_2_5_13_2","doi-asserted-by":"crossref","unstructured":"Takamori M Okumura S Nagata M. Myasthenogenic significance of synthetic alpha\u2010subunit peptide 183\u2010200 ofTorpedo californicaand human acetylcholine receptor.J Neurol Sci1988;85:121\u20139.","DOI":"10.1016\/0022-510X(88)90150-5"},{"key":"e_1_2_5_14_2","first-page":"61","article-title":"Anti\u2010acetylcholine receptor blocking antibody specifically adsorbed on plasmaadsorber MG50 in the treatment of myasthenia gravis.","volume":"14","author":"Ide Y","year":"1995","journal-title":"Jpn J Apheresis"},{"key":"e_1_2_5_15_2","first-page":"67","article-title":"Analysis of adsorbed plasma proteins on specific immunoadsorbent containing immobilized synthetic peptide of acetylcholine receptor.","volume":"14","author":"Oka K","year":"1995","journal-title":"Jpn J Apheresis"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90360-B"},{"key":"e_1_2_5_17_2","unstructured":"Hashimoto K Higashiyama M Shirakata Y Amagai M Oka K Nakaji S. Apheresis therapy for pemphingus vulgaris with peptide antigen affinity column.Jpn J Apheresis15(Suppl):s36."},{"key":"e_1_2_5_18_2","unstructured":"Japanese patent application No. 263795\/1994."}],"container-title":["Therapeutic Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1526-0968.2001.00360.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-0968.2001.00360.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:52:35Z","timestamp":1697521955000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1526-0968.2001.00360.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["10.1046\/j.1526-0968.2001.00360.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1526-0968.2001.00360.x","archive":["Portico"],"relation":{},"ISSN":["1091-6660","1526-0968"],"issn-type":[{"value":"1091-6660","type":"print"},{"value":"1526-0968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}